| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.211 | 32.914 | 43.857 | 54.605 | 68.108 | 97.367 | 116.686 | 110.371 | 146.457 |
| Total Income - EUR | - | 1.211 | 35.478 | 43.859 | 54.629 | 68.129 | 99.152 | 120.230 | 114.542 | 146.475 |
| Total Expenses - EUR | - | 1.067 | 21.819 | 26.573 | 27.792 | 31.443 | 35.398 | 54.916 | 62.584 | 109.531 |
| Gross Profit/Loss - EUR | - | 144 | 13.660 | 17.286 | 26.838 | 36.686 | 63.755 | 65.314 | 51.958 | 36.945 |
| Net Profit/Loss - EUR | - | 132 | 13.308 | 16.848 | 26.292 | 36.069 | 62.781 | 64.145 | 50.853 | 35.480 |
| Employees | - | 1 | 2 | 2 | 2 | 2 | 4 | 4 | 0 | 0 |
Check the financial reports for the company - Sonomed Biolife S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 29 | 8.813 | 8.322 | 7.560 | 7.495 | 23.533 | 19.256 | 66.434 | 71.422 |
| Current Assets | - | 1.767 | 35.497 | 68.645 | 93.092 | 116.976 | 131.785 | 119.289 | 163.968 | 194.520 |
| Inventories | - | 525 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 589 | 27.776 | 67.073 | 89.663 | 113.979 | 111.709 | 111.964 | 161.582 | 187.504 |
| Cash | - | 652 | 7.721 | 1.573 | 3.429 | 2.997 | 20.076 | 7.325 | 2.386 | 7.016 |
| Shareholders Funds | - | 177 | 13.482 | 30.082 | 55.791 | 90.803 | 90.925 | 94.519 | 145.085 | 104.366 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.062 | 30.828 | 46.885 | 44.862 | 33.669 | 55.475 | 38.485 | 71.663 | 147.998 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 8.918 | 5.542 | 13.654 | 13.578 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sonomed Biolife S.r.l.